Meet the visionary leaders guiding SAI Parenterals towards excellence in pharmaceutical manufacturing.

Managing Director
With over three decades of experience in the pharmaceutical industry, Anil Kumar leads the strategic direction and growth of SAI Group. He brings deep expertise across manufacturing and commercial operations, having guided the company through capacity expansion, entry into regulated markets, and value-accretive acquisitions.

Whole-time Director
Vijitha Gorrepati brings more than 14 years of experience across procurement, technical operations, and quality-driven manufacturing environments. She has played a key role in building robust supply chain systems and improving operational efficiencies across the company's facilities.

Non-Executive Director
Mrs. Aruna Karusala has been a guiding force in the Group's operations since 1989, bringing decades of hands-on experience across pharmaceutical manufacturing and organizational management.

Managing Director, Noumed Pharmaceuticals
With 30 years of experience spanning consumer healthcare and pharmaceuticals, Mark leads the Group's international operations through Noumed.

Director, Noumed Pharmaceuticals
Jo-Maree Delac has over 20 years of experience in pharmaceutical quality systems and Good Manufacturing Practice (GMP) compliance.

Chief Executive Officer
With more than 37 years in the pharmaceutical sector, Venkoji Prakash oversees production, validation, and operational execution across the company.

Chief Financial Officer
Anil Kumar leads the financial strategy of the organization, overseeing planning, budgeting, capital allocation, and financial controls.